In New Zealand, GLP-1 products approved for use for weight management are types of liraglutide (Saxenda, Victoza, Benedo) and semaglutide (Ozempic, Wegovy), the Ministry of Health said
These three factors combine to create the most efficient absorption surface available outside of injection
doi: 10.1016/j.molmet.2018.05.014 [DOI] [PMC free article] [PubMed] [Google Scholar] 52.Mori Y, Kushima H, Koshibu M, et al
For instance, Hulst et al (2021)178 recommended continuation of all GLP-1RAs therapies throughout the perioperative period
We adhere to current regulations and ethical sourcing
Thus, exenatide treated patients maintained their cognitive benefit 12-months following drug cessation, however, it should be noted that cognitive scores also remained unchanged for controls between 12 and 24 months